Advanced Enzyme Technologies Limited reported zero equity shares bought back on October 8, 2026, marking a pause in its open market buyback program for the day.

Emkay Global Financial Services Limited, the Manager to the Buyback, reported no transactions on either the National Stock Exchange (NSE) or the Bombay Stock Exchange (BSE). The cumulative number of equity shares bought back remains unchanged at 17,95,324. No quantity was closed out during this period.

Daily Buyback Report (Oct 8)

The daily report submitted to the stock exchanges confirms no acquisition activity on this date. The cumulative total holds steady from the previous report dated October 7, 2026.

Buyback Progress Update

As of October 8, 2026, the cumulative number of equity shares bought back stood at 17,95,324. This figure is identical to the total reported as of October 7, 2026. The progress moves the company closer to its initial deployment target of ₹278,800,000, which must be utilized within the first half of the offer period. The total quantity closed out remains at zero.

Buyback Offer Parameters

The buyback targets up to 1,394,000 equity shares, constituting approximately 1.24% of the total paid-up equity share capital as of August 8, 2026. The maximum buyback size is ₹697,000,000, funded entirely from free reserves and internal accruals with no borrowed funds utilized.

The company is required to utilize at least 75% of the Maximum Buyback Size, i.e., ₹522,750,000. Furthermore, at least 40% of the Buyback Size, i.e., ₹278,800,000, must be deployed within the initial half of the Offer Period. The buyback offer is expected to open on or before August 14, 2026, and close no later than November 20, 2026, being sixty-six Working Days from the opening date.

Premium and Market Context

The Maximum Buyback Price of ₹500 carries a substantial premium over recent market benchmarks. On August 8, 2026, the closing market price was ₹324.40 on BSE and ₹324.35 on NSE. The last reported acquisition price of ₹272.3684 on October 7 remains well below the maximum ceiling.

This premium reflects management’s confidence in the intrinsic value of the shares and serves as a strong signal to investors regarding the company’s financial health and future prospects.

Capital Structure Impact

If the full Maximum Buyback Size is utilized at the Maximum Buyback Price, the issued, subscribed, and paid-up capital will reduce from 111,976,150 shares to 110,582,150 shares. Promoters and persons in control are excluded from participating in the buyback; their shares will remain frozen at the ISIN level from August 8, 2026, until the buyback closes.

Financial Health and Rationale

The buyback is underpinned by strong financial performance. For Q1FY27 (ended June 30, 2026), the company reported Revenue from Operations of ₹1,158.57 million and Profit After Tax of ₹223.46 million. In FY26, Revenue from Operations stood at ₹4,527.66 million with a PAT of ₹1,318.06 million.

The Board confirmed that the company has no subsisting defaults in repayment of deposits, debentures, preference shares, dividends, or term loans. A cash escrow of ₹174,250,000 (25% of Maximum Buyback Size) has been deposited with HDFC Bank Limited. Emkay Global Financial Services Limited serves as the Manager to the Buyback, while MUFG Intime India Private Limited is the Registrar. The process complies with Regulation 5(vii) of the SEBI (Buy-back of Securities) Regulations, 2018, and relevant provisions of the Companies Act, 2013.

Advanced Enzyme Technologies Ltd has received a revised request from Radhika Ashish Pujara, a member of its Promoter Group, seeking reclassification to the Public category. The request was submitted on September 28, 2026, and received by the company on September 29, 2026.

This development follows an earlier intimation dated September 5, 2026. The reclassification is sought under Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company stated that the request remains subject to approval by its Board of Directors and the stock exchanges.

Reclassification details

Radhika Ashish Pujara currently holds no equity shares in the company. Her shareholding percentage is also nil. The following table outlines her current status:

Declarations made

In her letter to the Board of Directors, Pujara confirmed that she does not hold any equity shares or voting rights in the company. She further declared that she does not exercise control over the affairs of the company, either directly or indirectly. Key points from her declaration include:

• She is not involved in the management or day-to-day affairs of the company.
• She holds no special rights through any formal or informal arrangement, including shareholder agreements.
• She is not represented on the Board of Directors and is not a Key Managerial Personnel.
• She is not acting as a promoter or holding herself out as one.
• She is not acting in concert with existing Promoters or the Promoter Group.
• There are no circumstances allowing her to exercise control or influence over the company's management.
• She is not a wilful defaulter as per Reserve Bank of India guidelines nor a fugitive economic offender.

Pujara requested the Board to initiate the process for her reclassification and undertake all necessary corporate and regulatory actions, including applications to stock exchanges. The company signed the intimation via Sanjay Basantani, Company Secretary and Head-Legal.